Most organizations already have some kind of AI policy. It might be a slide deck, a PDF, or a page on the intranet that talks ...
Objectives To evaluate the performance of large language models (LLMs) in risk of bias assessment and to examine whether ...
The article explains how simplifying GST laws, rationalising returns, and improving the GST portal can significantly reduce compliance burdens for businesses and ...
Thursday, May 7, 2026 at 10:30 a.m. ET Chief Executive Officer — John Hewitt Chief Operating Officer — Sean Payne Chief Financial Officer — Kevin Cavanah Director of Investor Relations — Patrick ...
Explore the ultimate guide to automated brain organoid culture workflows and learn how the CellXpress.ai system enables scalable ...
Q1 2026 Earnings Call May 25, 2026 7:00 AM EDTCompany ParticipantsWill TanJay Xiao - Chairman & CEOZhanwen Qiao - ...
Thanks for joining us today for our first quarter 2026 earnings call. In the first quarter, against the backdrop of ...
Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors ...
Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue regeneration, today announced the launch of a preclinical development program for B.R.E.A.S.
Researchers built delta-mem to give AI agents working memory at 0.12% parameter overhead, outperforming RAG and context ...
Bernstein 42nd Annual Strategic Decisions Conference May 27, 2026 8:00 AM EDTCompany ParticipantsEnrique Lores - President, ...